Altre lingue CareDx, Inc

Azioni

CDNA

US14167L1035

Tempo reale stimato Cboe BZX Altri mercati azionari 16:28:20 19/04/2024			Variaz. 5gg	Var. 1 gen.
8,17 ^USD	+1,24%		-4,45%	-32,08%

16/04	CareDx, Inc. nomina John W. Hanna come Amministratore delegato	CI
16/04	CareDx, Inc. nomina John W. Hanna Presidente e membro del Consiglio di Amministrazione	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

CareDx Appoints John Hanna as CEO, President	16/04
CareDx Appoints John W. Hanna as its New President and Chief Executive Officer	16/04
CareDx, Inc Appoints John W. Hanna as Chief Executive Officer	16/04
CareDx, Inc Appoints John W. Hanna as President and Member of the Board of Directors	16/04
Illumina CFO Goswami to depart, former Summit Therapeutics exec Dhingra to succeed	09/04
CareDx et ses collaborateurs présentent les dernières avancées dans le domaine cardio-thoracique lors de la réunion 2024 de la Société internationale de transplantation cardiaque et pulmonaire	09/04
CareDx und Mitarbeiter präsentieren neueste Herz-Thorax-Fortschritte im Rahmen des 2024 International Society for Heart and Lung Transplantation Meeting	09/04
CareDx and Collaborators Present Latest Cardiothoracic Advancements at the 2024 International Society for Heart and Lung Transplantation Meeting	09/04
CareDx Appoints Bryan Riggsbee to Its Board of Directors	11/03
CareDx, Inc Appoints Bryan Riggsbee to Its Board of Directors	11/03
CareDx : Appoints Bryan Riggsbee to Its Board of Directors - Form 8-K	11/03
CareDx : Corporate Presentation February 2024	01/03
CareDx: Q4 Earnings Snapshot	28/02
Earnings Flash (CDNA) CAREDX Reports Q4 Revenue $65.6M, vs. Street Est of $64.1M	28/02
CareDx, Inc Provides Revenue Guidance for the Full Year of 2024	28/02
CareDx Announces Fourth Quarter and Full Year 2023 Financial Results	28/02
CareDx, Inc Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	28/02
CareDx to Participate in the Raymond James & Associates’ 45th Annual Institutional Investors Conference	27/02
CareDx to Report Fourth Quarter and Full Year 2023 Financial Results	21/02
CareDx Showcases Digital Solutions and Pipeline in Cellular Transplant and Therapy Monitoring at the 2024 Tandem Meetings	21/02

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue CareDx, Inc

Azioni

CDNA

US14167L1035

Altre lingue

Filtri